Literature DB >> 28598542

Overexpression of minichromosome maintenance protein 10 in medulloblastoma and its clinical implications.

Daniel Senfter1, Erdogan Pekcan Erkan1, Erdener Özer2, Gerhard Jungwirth1, Sibylle Madlener1, Marcel Kool3, Thomas Ströbel4, Nurten Saydam1,5, Okay Saydam1,5.   

Abstract

BACKGROUND: Overexpression of minichromosome maintenance (MCM) proteins 2, 3, and 7 is associated with migration and invasion in medulloblastoma (MB). However, expression profiling of all prereplication complex (pre-RC) has not been addressed in MBs. PROCEDURE: We performed mRNA expression profiling of a large set of pre-RC elements in cell lines and tumor tissues of MB. RNAi technology was employed for functional studies in MB cell lines.
RESULTS: Our data showed that most of the pre-RC components are significantly overexpressed in MB. Among all pre-RC mRNAs, MCM10 showed the highest level of expression (∼500- to 1,000-fold) in MB cell lines and tissues compared to the levels detected in cerebellum. In addition, RNAi silencing of MCM10 caused reduced cell proliferation and cell viability in MB cells.
CONCLUSIONS: Taken together, our study reveals that the pre-RC is dysregulated in MB. In addition, MCM10, a member of this complex, is significantly overexpressed in MB and is required for tumor cell proliferation.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  MCM10; medulloblastoma; minichromosome maintenance protein; prereplication complex

Mesh:

Substances:

Year:  2017        PMID: 28598542     DOI: 10.1002/pbc.26670

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Knockdown of MCM10 Gene Impairs Glioblastoma Cell Proliferation, Migration and Invasion and the Implications for the Regulation of Tumorigenesis.

Authors:  Peng Kang; Zhe Han; Zhiyi Liao; Heng Zhang; Wang Jia; Yongji Tian
Journal:  J Mol Neurosci       Date:  2020-02-06       Impact factor: 3.444

2.  Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer.

Authors:  Feilun Cui; Jianpeng Hu; Songyi Ning; Jian Tan; Huaming Tang
Journal:  Prostate       Date:  2018-08-10       Impact factor: 4.104

3.  The anti-parasitic agent suramin and several of its analogues are inhibitors of the DNA binding protein Mcm10.

Authors:  Carolyn N Paulson; Kristen John; Ryan M Baxley; Fredy Kurniawan; Kayo Orellana; Rawle Francis; Alexandra Sobeck; Brandt F Eichman; Walter J Chazin; Hideki Aihara; Gunda I Georg; Jon E Hawkinson; Anja-Katrin Bielinsky
Journal:  Open Biol       Date:  2019-08-14       Impact factor: 6.411

4.  Synergistic effects of methyl 2-cyano-3,11-dioxo-18beta-olean-1,-12-dien-30-oate and erlotinib on erlotinib-resistant non-small cell lung cancer cells.

Authors:  Ebony Nottingham; Elizabeth Mazzio; Sunil Kumar Surapaneni; Shallu Kutlehria; Arindam Mondal; Ramesh Badisa; Stephen Safe; Arun K Rishi; Mandip Singh
Journal:  J Pharm Anal       Date:  2021-06-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.